Late Effects following Hematopoietic Cell Transplantation for Children

Biology of Blood and Marrow Transplantation

Volumn 14, Issue 1 SUPPL., 2008, Pages 88-93

  Dahllöf, Göran ^a   Hingorani, Sangeeta R ^b   Sanders, Jean E ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; BUSULFAN; CALCIUM; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; GLUCOCORTICOID; GROWTH HORMONE; IMATINIB; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; SEX HORMONE; STEROID; THYROXINE; VITAMIN D;

ACUTE GRAFT VERSUS HOST DISEASE; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL FEATURE; CORTICOSTEROID INDUCED OSTEOPOROSIS; DEVELOPMENTAL DISORDER; DIABETES MELLITUS; DISEASE CLASSIFICATION; DISEASE CONTROL; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DUAL ENERGY X RAY ABSORPTIOMETRY; ECHOGRAPHY; FOLLOW UP; GONAD DYSFUNCTION; GROWTH DISORDER; GROWTH HORMONE DEFICIENCY; HEMATOLOGIC DISEASE; HLA MATCHING; HUMAN; HYPOTHYROIDISM; IMMUNE DEFICIENCY; INFECTION RISK; LEUKEMIA; LEUKEMIA RELAPSE; LOW DRUG DOSE; LUNG FUNCTION TEST; MONOTHERAPY; MORTALITY; OSTEOPENIA; OSTEOPOROSIS; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; QUALITY OF LIFE; RESPIRATORY TRACT DISEASE; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SURVIVAL TIME; SYMPTOM; TREATMENT DURATION; WHOLE BODY RADIATION;

CHILD; DIABETES MELLITUS; ENDOCRINE SYSTEM DISEASES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LUNG DISEASES; OSTEOPOROSIS; RECURRENCE; TIME FACTORS;

EID: 37349025441     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2007.10.018     Document Type: Article

References (42)

1. Woolfrey A.E., Anasetti C., Petersdorf E.W., Martin P.J., Sanders J.E., and Hansen J.A. Unrelated donor marrow transplantation for treatment of childhood hematologic malignancies-effect of HLA disparity and cell dose. In: Burt R.K., and Brush M.M. (Eds). Advances in Allogeneic Hematopoietic Stem Cell Transplantation (1999), Kluwer Academic Publishers, Norwall, MA 25-51
2. Radich J.P. Molecular measurement of minimal residual disease in Philadelphia-positive acute lymphoblastic leukaemia. Best Prac Res Clin Haematol 15 (2002) 91-103
3. Radich J.P., Gehly G., Gooley T., et al. Polymerase chain reaction detection of the BCR-ABL fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: results and implications in 346 patients. Blood 85 (1995) 2632-2638
4. Meshinchi S., Leisenring W.M., Carpenter P.A., et al. Survival after second hematopoietic stem cell transplantation for recurrent pediatric acute myeloid leukemia. Biol Blood Marrow Transplant 9 (2003) 706-713
5. Stewart B.L., Storer B., Storek J., et al. Duration of immunosuppressive treatment for chronic graft-versus-host disease. Blood 104 (2004) 3501-3506
6. Filipovich A.H., Weisdorf D., Pavletic S., et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant 11 (2005) 945-956
7. Leahey A.M., Teunissen H., Friedman D.L., Moshang T., Lange B.J., and Meadows A.T. Late effects of chemotherapy compared to bone marrow transplantation in the treatment of pediatric acute myeloid leukemia and myelodysplasia. Med Pediatr Oncol 32 (1999) 163-169
8. Leung W., Hudson M.M., Strickland D.K., et al. Late effects of treatment in survivors of childhood acute myeloid leukemia. J Clin Oncol 18 (2000) 3273-3279
9. Shalet S.M., Clayton P.E., and Price D.A. Growth and pituitary function in children treated for brain tumours or acute lymphoblastic leukaemia. Horm Res 30 (1988) 53-61
10. Sanders J.E., Buckner C.D., Sullivan K.M., et al. Growth and development in children after bone marrow transplantation. Horm Res 30 (1988) 92-97
11. Cohen A., Rovelli A., Bakker B., et al. Final height of patients who underwent bone marrow transplantation for hematological disorders during childhood: a study by the Working Party for Late Effects-EBMT. Blood 93 (1999) 4109-4115
12. Afify Z., Shaw P.J., Clavano-Harding A., and Cowell C.T. Growth and endocrine function in children with acute myeloid leukaemia after bone marrow transplantation using busulfan/cyclophosphamide. Bone Marrow Transplant 25 (2000) 1087-1092
13. Sanders J.E., Pritchard S., Mahoney P., et al. Growth and development following marrow transplantation for leukemia. Blood 68 (1986) 1129-1135
14. Brauner R., Adan L., Souberbielle J.C., et al. Contribution of growth hormone deficiency to the growth failure that follows bone marrow transplantation. J Pediatr 130 (1997) 785-792
15. Thomas B.C., Stanhope R., Plowman P.N., and Leiper A.D. Growth following single fraction and fractionated total body irradiation for bone marrow transplantation. Eur J Pediatr 152 (1993) 888-892
16. Sanders J.E., Guthrie K.A., Hoffmeister P.A., Woolfrey A.E., Carpenter P.A., and Appelbaum F.R. Final adult heights of patients who received hematopoietic cell transplantation in childhood. Blood 105 (2005) 1348-1354
17. Giorgiani G., Bozzola M., Locatelli F., et al. Role of busulfan and total body irradiation on growth of prepubertal children receiving bone marrow transplantation and results of treatment with recombinant human growth hormone. Blood 86 (1995) 825-831
18. Shalet S.M., Toogood A., Rahim A., and Brennan B.M. The diagnosis of growth hormone deficiency in children and adults. [Review]. Endocr Rev 19 (1998) 203-223
19. MacGillivray M.H., Baptista J., and Johanson A. Outcome of a four-year randomized study of daily versus 3 times weekly somatropin treatment in prepubertal naive growth hormone-deficient children. Genentech Study Group. J Clin Endocrinol Metab 81 (1996) 1806-1809
20. Berger C., Le-Gallo B., Donadieu J., et al. Late thyroid toxicity in 153 long-term survivors of allogeneic bone marrow transplantation for acute lymphoblastic leukaemia. Bone Marrow Transplant 35 (2005) 991-995
21. Shore R.E., Woodard E., Hildreth N., Dvoretsky P., Hempelmann L., and Pasternack B. Thyroid tumors following thymus irradiation. J Natl Cancer Inst 74 (1985) 1177-1184
22. Crom D.B., Kaste S.C., Tubergen D.G., Greenwald C.A., Sharp G.B., and Hudson M.M. Ultrasonography for thyroid screening after head and neck irradiation in childhood cancer survivors. Med Pediatr Oncol 28 (1997) 15-21
23. Bourguignon J.-P. Linear growth as a function of age at onset of puberty and sex steroid dosage: therapeutic implications. Endocr Rev 9 (1988) 467-488
24. Hoffmeister P.A., Storer B.E., and Sanders J.E. Diabetes mellitus in long-term survivors of pediatric hematopoietic cell transplantation. J Pediatr Hematol Oncol 26 (2004) 81-90
25. Taskinen M., Saarinen-Pihkala U.M., Hovi L., and Lipsanen-Nyman M. Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood. Lancet 356 (2000) 993-997
26. Traggiai C., Stanhope R., Nussey S., and Leiper A.D. Diabetes mellitus after bone marrow transplantation during childhood. Med Pediatr Oncol 40 (2003) 128-129
27. Reaven G.M. Role of insulin resistance in human disease (syndrome X): an expanded definition. [review]. Annu Rev Med 44 (1993) 121-131
28. Soubani A.O., Miller K.B., and Hassoun P.M. Pulmonary complications of bone marrow transplantation. [review]. Chest 109 (1996) 1066-1077
29. Griese M., Rampf U., Hofmann D., Fuhrer M., Reinhardt D., and Bender-Gotze C. Pulmonary complications after bone marrow transplantation in children: twenty-four years of experience in a single pediatric center. Pediatr Pulmonol 30 (2000) 393-401
30. Nysom K., Holm K., Hesse B., et al. Lung function after allogeneic bone marrow transplantation for leukaemia or lymphoma. Arch Dis Child 74 (1996) 432-436
31. Bossi G., Cerveri I., Volpini E., et al. Long-term pulmonary sequelae after treatment of childhood Hodgkin's disease. Ann Oncol 8 (1997) 19-24
32. Bacigalupo A., Bruno B., Saracco P., et al. Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO). Blood 95 (2000) 1931-1934
33. Cerveri I., Zoia M.C., Fulgoni P., et al. Late pulmonary sequelae after childhood bone marrow transplantation. Thorax 54 (1999) 131-135
34. Hoffmeister P.A., Madtes D.K., Storer B.E., and Sanders J.E. Pulmonary function in long-term survivors of pediatric hematopoietic cell transplantation. Pediatr Blood Cancer 47 (2006) 594-606
35. Hui S.L., Slemenda C.W., and Johnston Jr. C.C. The contribution of bone loss to postmenopausal osteoporosis. Osteoporos Int 1 (1990) 30-34
36. Marshall D., Johnell O., and Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312 (1996) 1254-1259
37. Bhatia S., Ramsay N.K., Weisdorf D., Griffiths H., and Robison L.L. Bone mineral density in patients undergoing bone marrow transplantation for myeloid malignancies. Bone Marrow Transplant 22 (1998) 87-90
38. Stern J.M., Chesnut III C.H., Bruemmer B., et al. Bone density loss during treatment of chronic GVHD. Bone Marrow Transplant 17 (1996) 395-400
39. Weilbaecher K.N. Mechanisms of osteoporosis after hematopoietic cell transplantation (Review). Biol Blood Marrow Transplant 6 (2000) 165-174
40. Ebeling P.R., Thomas D.M., Erbas B., Hopper J.L., Szer J., and Grigg A.P. Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation. J Bone Mineral Res 14 (1999) 342-350
41. Schulte C.M., and Beelen D.W. Bone loss following hematopoietic stem cell transplantation: a long-term follow-up. Blood 103 (2004) 3635-3643
42. Carpenter P.A., Hoffmeister P., Chesnut III C.H., et al. Bisphosphonate therapy for reduced bone mineral density in children with chronic graft-versus-host disease. Biol Blood Marrow Transplant 13 (2007) 683-690